Find clinical trials for M.D. Anderson. Search for M.D. Anderson clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 530
Evaluating Occupational Stress in Surgeons and Musicians: A Multi-modal Pilot Study Using Wearable EEG, Biomarker Analysis and Validated Questionnaires
for
Occupational Stress
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06875882
Recruiting
Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC
for
Spinal Disease
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05709782
Phase 2, Recruiting
Intelligent Optical Probe for Guiding Core Needle Biopsy Procedures
for
Needle Biopsy
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06199492
Recruiting
A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
for
Acute Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 12+
Code: NCT05360160
Phase 1, Phase 2, Recruiting
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
for
Acute Myeloid Leukemia,
Location: Boston MA, Cleveland OH, Houston TX, Portland OR
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03471260
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
for
Amputation
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06840262
Recruiting
Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic
for
Cancer, Occupational Therapy
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06329531
Recruiting
Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas
for
Gliomas
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05804227
Early Phase 1, Recruiting
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
for
Brain Lesion
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03458676
Recruiting
Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce
for
COVID-19 Infection
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04491292
Recruiting
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
for
Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 1+
Code: NCT03630991
Phase 1, Recruiting
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
for
Neuropathy;Peripheral
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06121232
Recruiting
Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07579221
Phase 1, Phase 2, Recruiting
Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
for
Prostate Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Male
Age: 18+
Code: NCT07377006
Recruiting
Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma
for
Phase II, Sacituzumab, Tirumotecan,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07438626
Phase 2, Recruiting
Prospective Observational Study Of Geniculate Artery Embolization For Symptomatic Knee Osteoarthritis In A Cancer Population